These data demonstrated that despite completely removing tumor cells, plasma sPD-L1 levels were temporarily increased and then subsequently recovered to the initial levels, suggesting that some factor(s) other than tumor cells, such as an inflammatory immune response, might contribute to sPD-L1 levels in peripheral blood. Here, SPDL1 is linked to neoplasm.